Breast Cancer-Clinical Trials

  • Phase 1 (phase I) trials study whether a new treatment is safe to use over a range of doses. The treatment may be given to people with different types of cancers.

  • A phase 1 trial is mainly a drug safety study.

  • Phase 2 (phase II) trials study how well a treatment works for certain cancer, such as breast cancer.  These trials may include between 25 and 100 people.

  • After a drug (or other therapy) is found to be effective in treating breast cancer in a phase 2 trials, a phase 3 trial will study it further.

  • Phase 3 (phase III) trials study how well a new treatment (including surgical procedures) works compared to the standard treatment (standard of care).

  • Phase 4 (phase IV) trials study the long-term side effects of treatments or answer new questions about the treatment.

    Related Conference of Breast Cancer-Clinical Trials

    March 18-19, 2024

    5th Global Summit on Oncology and Hematology

    Zurich, Switzerland
    June 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Barcelona, Spain
    July 11-12, 2024

    24th World Congress on Cancer and Diagnostics

    Vancouver, Canada
    July 18-19, 2024

    14th World Congress on Breast Cancer

    Paris, France
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France

    Breast Cancer-Clinical Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in